JBC Anatrace, Inc.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M507221200 on July 26, 2005

J. Biol. Chem., Vol. 280, Issue 38, 32625-32633, September 23, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/38/32625    most recent
M507221200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ferreira, I. A.
Right arrow Articles by Akkerman, J.-W. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ferreira, I. A.
Right arrow Articles by Akkerman, J.-W. N.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Glucose Uptake via Glucose Transporter 3 by Human Platelets Is Regulated by Protein Kinase B*

Irlando Andrade Ferreira, Astrid I. M. Mocking, Rolf T. Urbanus, Samantha Varlack, Monika Wnuk, and Jan-Willem N. Akkerman1

From the Thrombosis and Haemostasis Laboratory, Department of Hematology, University Medical Center Utrecht, and the Institute for Biomembranes, Utrecht University, HP G03.647, Heidelberglaan 100, Utrecht 3584 CX, the Netherlands

In insulin-responsive tissues, insulin is a potent activator of protein kinase B (PKB)-mediated glucose uptake through the facilitative glucose transporter GLUT4. In platelets, glucose uptake is mediated through GLUT3, which is present in plasma (15%) and intracellular {alpha}-granule (85%) membranes. Here we report the PKB-mediated glucose uptake by platelets by agents that do (thrombin) or do not (insulin) induce {alpha}-granule translocation to the plasma membrane. Both thrombin and insulin activate PKB and induce glucose uptake albeit with different kinetics. Inhibition of PKB by the pharmacological inhibitor ML-9 decreases thrombin-induced {alpha}-granule release and thrombin- and insulin-induced glucose uptake. At low glucose (0.1 mM), both agents stimulate glucose uptake by lowering the Km for glucose (thrombin and insulin) and increasing Vmax (thrombin). At high glucose (5 mM), stimulation of glucose uptake by insulin disappears, and insulin becomes an inhibitor of thrombin-induced glucose uptake via mechanisms independent of PKB. We conclude that in platelets glucose transport through GLUT3 is regulated by changes in surface expression and affinity modulation, which are both under control of PKB.


Received for publication, July 5, 2005

* This work was supported in part by the Dutch Diabetes Research Foundation (Grant 1999.046) and the Fonds voor het Hart. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Supported by the Dutch Thrombosis Foundation. To whom correspondence should be addressed. Tel.: 31-30-250-6512; Fax: 31-30-251-1893; E-mail: j.w.n.akkerman{at}azu.nl.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
I. A. Simpson, D. Dwyer, D. Malide, K. H. Moley, A. Travis, and S. J. Vannucci
The facilitative glucose transporter GLUT3: 20 years of distinction
Am J Physiol Endocrinol Metab, August 1, 2008; 295(2): E242 - E253.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
H. M.W. Verheul, M. P.J. Lolkema, D. Z. Qian, Y. H.A. Hilkes, E. Liapi, J.-W. N. Akkerman, R. Pili, and E. E. Voest
Platelets Take Up the Monoclonal Antibody Bevacizumab
Clin. Cancer Res., September 15, 2007; 13(18): 5341 - 5347.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
I. A. Ferreira, A. I.M. Mocking, M. A.H. Feijge, G. Gorter, T. W. van Haeften, J. W.M. Heemskerk, and J.-W. N. Akkerman
Platelet Inhibition by Insulin Is Absent in Type 2 Diabetes Mellitus
Arterioscler. Thromb. Vasc. Biol., February 1, 2006; 26(2): 417 - 422.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.